Publications

Berlin, J, Ramanathan, RK, Strickler, JH, Subramaniam, DS, Marshall, J, Kang, Y-K, Hetman, R, Dudley, MW, Zeng, J, Nickner, C, Xiong, H, Komarnitsky, P, Shepherd, SP, Hurwitz, H, and Lenz, H-J. "A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours." March 12, 2018.

PMID
29527010
Full Text

Rathkopf, DE, Beer, TM, Loriot, Y, Higano, CS, Armstrong, AJ, Sternberg, CN, de Bono, JS, Tombal, B, Parli, T, Bhattacharya, S, Phung, D, Krivoshik, A, Scher, HI, and Morris, MJ. "Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial." JAMA oncology (March 8, 2018).

PMID
29522174
Full Text

Cline, JM, Dugan, G, Bourland, JD, Perry, DL, Stitzel, JD, Weaver, AA, Jiang, C, Tovmasyan, A, Owzar, K, Spasojevic, I, Batinic-Haberle, I, and Vujaskovic, Z. "Post-Irradiation Treatment with a Superoxide Dismutase Mimic, MnTnHex-2-PyP5+, Mitigates Radiation Injury in the Lungs of Non-Human Primates after Whole-Thorax Exposure to Ionizing Radiation." Antioxidants (Basel, Switzerland) 7, no. 3 (March 7, 2018).

PMID
29518913
Full Text

Varga, MG, Wang, T, Cai, H, Xiang, Y-B, Gao, Y-T, Ji, B-T, Pawlita, M, Waterboer, T, Zheng, W, Shu, X-O, and Epplein, M. "Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27, no. 3 (March 2018): 342-344.

PMID
29263184
Full Text

Shih, Y-CT, Nasso, SF, and Zafar, SY. "Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care." PharmacoEconomics 36, no. 3 (March 2018): 259-261.

PMID
29396743
Full Text

Khozin, S, Abernethy, AP, Nussbaum, NC, Zhi, J, Curtis, MD, Tucker, M, Lee, SE, Light, DE, Gossai, A, Sorg, RA, Torres, AZ, Patel, P, Blumenthal, GM, and Pazdur, R. "Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval." Oncologist 23, no. 3 (March 1, 2018): 328-336.

Full Text

Henderson, TO, and Oeffinger, KC. "Addressing the health burden of childhood cancer survivors improvements are needed." Nature Reviews Clinical Oncology 15, no. 3 (March 1, 2018): 137-138.

Full Text

Overman, MJ, Lonardi, S, Wong, KYM, Lenz, H-J, Gelsomino, F, Aglietta, M, Morse, MA, Van Cutsem, E, McDermott, R, Hill, A, Sawyer, MB, Hendlisz, A, Neyns, B, Svrcek, M, Moss, RA, Ledeine, J-M, Cao, ZA, Kamble, S, Kopetz, S, and André, T. "Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 36, no. 8 (March 2018): 773-779.

PMID
29355075
Full Text

Kolmar, A, and Kamal, AH. "Developing a Path to Improve Cultural Competency in Islam Among Palliative Care Professionals." Journal of pain and symptom management 55, no. 3 (March 2018): e1-e3. (Letter)

PMID
29154889
Full Text

Kamal, AH, Kirkland, KB, Meier, DE, Morgan, TS, Nelson, EC, and Pantilat, SZ. "A Person-Centered, Registry-Based Learning Health System for Palliative Care: A Path to Coproducing Better Outcomes, Experience, Value, and Science." Journal of palliative medicine 21, no. S2 (March 2018): S61-S67.

PMID
29091509
Full Text

Pages